Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 1/20 | 0.54 |
| ▸ | CA1 | P00915 | 1/20 | 0.54 |
| ▸ | CA2 | P00918 | 1/20 | 0.54 |
| ▸ | CA9 | Q16790 | 1/20 | 0.54 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.54 |
| ▸ | NAMPT | P43490 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | SCD | O00767 | 1/20 | 0.38 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
| ▸ | FNTA | P49354 | 6/20 | 0.36 |
| ▸ | FNTB | P49356 | 6/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.35 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.35 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.35 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24379050 | 0.86 | CA12 (0.58) | CA12CA1CA2CA9CA14 | |
| SCHEMBL26726417 | 0.83 | CA12 (0.55) | CA12CA1CA2CA9CA14 | |
| SCHEMBL17253366 | 0.81 | CA1 (0.52) | CA12CA1CA2CA9CA14 | |
| SCHEMBL7210123 | 0.77 | CA12 (0.68) | CA12CA1CA2CA9CA14 | |
| SCHEMBL4891137 | 0.76 | KDM4E (0.56) | CA12CA1CA2CA9CA14 | |
| SCHEMBL25318565 | 0.75 | CA12 (0.47) | CA12CA1CA2CA9CA14 | |
| SCHEMBL31116810 | 0.75 | KDM4E (0.54) | CA12CA1CA2CA9CA14 | |
| SCHEMBL20116196 | 0.74 | CA1 (0.59) | CA12CA1CA2CA9CA14 | |
| SCHEMBL17689597 | 0.74 | NR1H4 (0.56) | CA12CA1CA2CA9CA14 | |
| SCHEMBL28856783 | 0.74 | CA2 (0.68) | CA12CA1CA2CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250059229-A1 | Compositions and Methods for Selective Labeling of Secondary Amines | UNIV EMORY (US) | 2025-02-20 | — | — | US | disclosed |
| WO-2023114963-A1 | COMPOSITIONS AND METHODS FOR SELECTIVELY LABELING SECONDARY AMINES | EMORY UNIVERSITY (US) | 2023-06-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250059229-A1 | Compositions and Methods for Selective Labeling of Secondary Amines | RNMT, DOT1L, ADAR | CA12 2899/4885CA1 2340/4885CA2 2391/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.